GE HEALTHCARE TECHNOLOGY (GEHC)
US36266G1076 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.585B 2.45% | 18.341B 4.30% | 19.552B 6.60% | 20.08B 2.70% | 20.888B 4.02% | 21.794B 4.34% | 22.798B 4.61% | 23.946B 5.04% | |
| EBITDA YoY % growth | 3.42B 2.09% | 3.155B -7.75% | 3.045B -3.49% | 3.774B 23.94% | 4.1B 8.64% | 4.3B 4.88% | 4.422B 2.84% | 4.691B 6.08% | |
| EBIT YoY % growth | 2.795B 2.76% | 2.522B -9.77% | 2.435B -3.45% | 3.153B 29.49% | 3.373B 6.98% | 3.706B 9.87% | 4.033B 8.82% | 4.458B 10.54% | |
| Operating Margin | 15.89% | 13.75% | 12.45% | 15.70% | 16.15% | 17.00% | 17.69% | 18.62% | |
| EPS YoY % growth | N/A | N/A | 3.94 10.02% | 4.38 11.13% | 4.76 8.63% | 5.29 11.30% | 5.80 9.48% | 6.28 8.41% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.29 9.07% | 1.01 12.54% | 1.12 12.28% | 1.20 5.58% | 1.38 7.55% |
| Revenue Q2Q % growth | 5.449B 4.67% | 4.874B 4.82% | 5.09B 5.19% | 5.158B 6.07% | 5.71B 4.79% |
| EBITDA Q2Q % growth | 1.097B -15.55% | 892.67M 29.75% | 958.35M 5.90% | 1.032B -7.53% | 1.158B 5.56% |
| EBIT Q2Q % growth | 935.17M 35.73% | 727.55M 34.73% | 791.83M 30.24% | 847.55M 25.38% | 971.91M 3.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.14 15.15% | 1.07 | 0.07 | 6.17% |
| Q2 2024 Q2Q % growth | 1.00 8.70% | 1.00 | 0.00 | 0.18% |
| Q1 2024 Q2Q % growth | 0.90 5.88% | 0.92 | -0.02 | -2.68% |
| Q4 2023 Q2Q % growth | 1.18 -9.92% | 1.09 | 0.09 | 8.08% |
| Q3 2023 Q2Q % growth | 0.99 | 0.91 | 0.08 | 8.23% |
| Q2 2023 Q2Q % growth | 0.92 | 0.89 | 0.03 | 3.67% |
| Q1 2023 Q2Q % growth | 0.85 | 0.81 | 0.04 | 5.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.863B 0.85% | 4.966B | -103M | -2.07% |
| Q2 2024 Q2Q % growth | 4.839B 0.46% | 4.97B | -131M | -2.64% |
| Q1 2024 Q2Q % growth | 4.65B -1.21% | 4.897B | -247M | -5.04% |
| Q4 2023 Q2Q % growth | 5.206B 5.43% | 5.193B | 13M | 0.25% |
| Q3 2023 Q2Q % growth | 4.822B 5.38% | 4.901B | -79M | -1.61% |
| Q2 2023 Q2Q % growth | 4.817B -45.43% | 4.89B | -73M | -1.49% |
| Q1 2023 Q2Q % growth | 4.707B | 4.727B | -20M | -0.42% |
| Q4 2022 Q2Q % growth | 4.938B 7.61% | % | ||
| Q3 2022 Q2Q % growth | 4.576B 6.32% | % | ||
| Q2 2022 Q2Q % growth | 8.827B 1.55% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.76% | -0.03% | 1.16% |
| Revenue | 0% | -3.64% | -0.02% | -0.34% |